Efficacy [qlco]
Combined [qlco]
sevelamer [orch, phsu]
Calcium Carbonate [inch, phsu]
therapy [ftcn]
Hyperphosphataemia [dsyn]
Japanese [popg]
Haemodialysis [topp]
Patients [podg]
Japan [geoa]
Phosphate Binder [phsu]
Carbonate [inch]
Not available [idcn]
Patients [podg]
Long-term [tmco]
Haemodialysis [topp]
Evaluated [ftcn]
Clinical [qlco]
Efficacy [qlco]
Combination [qlco]
Sevelamer hydrochloride [orch, phsu]
Calcium Carbonate [inch, phsu]
Study [mnob]
Group [idcn]
Haemodialysis [topp]
Patients [podg]
Administered [ftcn]
Calcium Carbonate [inch, phsu]
mg day [qnco]
mg dl [qnco]
mmol/L [qnco]
Beginning [tmco]
Study [mnob]
Dose [qnco]
Calcium Carbonate [inch, phsu]
Reduced [qlco]
mg day [qnco]
Patients [podg]
divided [ftcn]
Two [qnco]
Group [idcn]
Dose [qnco]
Additional [ftcn]
Sevelamer hydrochloride [orch, phsu]
Group A [clas]
Group [idcn]
Oral [spco]
Active Vitamin D [lbpr]
therapy [ftcn]
Unchanged [fndg]
Patients [podg]
Dropped [acty]
Out [spco]
adverse effects [ftcn]
Remaining [qlco]
Patients [podg]
suffered [mobd]
gastrointestinal problems [qlco]
serum concentration [qnco]
Phosphate [inch, phsu]
Decreased [qnco]
mg dl [qnco]
mmol/L [qnco]
mg dl [qnco]
mmol/L [qnco]
P NOS [aapp, imft]
Group [idcn]
Only [qnco]
weeks [tmco]
Combination Therapy [topp]
Calcium phosphate product [inch, phsu]
CA X [gngm]
PI [clna]
Decreased [qnco]
Group [idcn]
Only [qnco]
mg% [qnco]
MMOLE [qnco]
mg% [qnco]
MMOLE [qnco]
P NOS [aapp, imft]
Combination [qlco]
Sevelamer hydrochloride [orch, phsu]
Calcium Carbonate [inch, phsu]
Regimen [topp]
treatment [ftcn]
Haemodialysis [topp]
Patients [podg]
Hypercalcaemia [dsyn]
Calcium Carbonate [inch, phsu]
adverse effects [ftcn]
Sevelamer hydrochloride [orch, phsu]
Single [popg]
Drug Therapy [topp]
Ability [orga]
Sevelamer hydrochloride [orch, phsu]
Decrease [qlco]
serum concentration [qnco]
Phosphate [inch, phsu]
mg% [qnco]
Calcium Carbonate [inch, phsu]
